CLINICAL_TRIALS
trial_result
· 2022-02-18
Clinical Trial Update: Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042) [Phase 3]
Summary
Phase 3 trial update evaluating etoricoxib for chronic recurrent low back pain has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Recurrent Low Back Pain | Phase 3 | Status: COMPLETED